GHK-Cu (often written GHKCu, GHK Cu, or just "copper peptide") is having a search-trend moment — serums, creams, injectable vials, and "stacks" all trading under one name. As usual in the peptide conversation, the products wearing the name live in very different worlds, and the marketing works hard to blur them. Here's the plain-English version: what GHK-Cu actually is, which forms are legitimate to buy, and where the line sits as of this writing.
The short version: GHK-Cu is a naturally occurring copper-binding tripeptide. As an ingredient in cosmetic serums and creams, it's legal and widely sold — as a cosmetic, with cosmetic-level evidence and cosmetic-level claims. As an injectable or oral product, it is not FDA-approved, is not lawfully available through pharmacy compounding as of this writing, and is sold only as a "research use only" vial — the gray market's label, not medicine's.
What GHK-Cu actually is
GHK is a tripeptide — three amino acids (glycine, histidine, lysine) — that occurs naturally in human plasma, saliva, and urine, usually found bound to copper, which is where the "-Cu" comes from. It was first isolated in the 1970s, and its circulating levels have been reported to decline with age — an observation that, as with NAD+, does a lot of heavy lifting in the marketing.
Researchers have studied GHK-Cu for decades, mostly in laboratory and animal models, with a smaller body of human research focused on skin appearance. The published research literature describes a wide range of biological activities; what exists in humans is largely small cosmetic studies rather than the large controlled trials that establish a medicine. That gap — interesting biology, limited human evidence — is the baseline for everything sold under this name.
The cosmetic lane: serums and creams
Most GHK-Cu products are cosmetics — copper-peptide serums and creams from mainstream skincare brands, sold over the counter. This is a legitimate, legal market, and it's worth being precise about what "legal" means here:
- Cosmetics are not FDA-approved. The FDA doesn't approve cosmetics before sale (color additives aside); it regulates them after the fact — they must be safe as used and accurately labeled. That's a lighter framework than drug approval, and it's the same one governing every moisturizer on the shelf.
- The claims must stay cosmetic. A cosmetic can claim to improve the appearance of skin. The moment a product claims to heal, repair, regrow, or treat, it's making drug claims — and a GHK-Cu serum marketed with drug claims is a product out over its skis.
- The evidence matches the category. Small studies have reported improvements in the appearance of aged skin with topical copper peptides. That's a reasonable cosmetic-ingredient evidence base. It is not proof of the sweeping regenerative effects the vial-sellers extrapolate from lab research.
If you want to try GHK-Cu without a prescription, this is the lane where a legitimate version of it exists today.
The injectable lane: a different story entirely
Injectable and oral GHK-Cu are where the copper-peptide conversation leaves medicine. As of this writing:
- No GHK-Cu injection is FDA-approved for any use.
- GHK-Cu is not on the FDA's list of substances allowed in pharmacy compounding, which means no licensed US pharmacy may lawfully prepare an injectable or oral GHK-Cu prescription. The vials sold online are "research use only" material — no prescriber, no pharmacy, no verified identity, purity, or sterility.
- The FDA is actively reviewing this space. GHK-Cu is among the compounds scheduled for the FDA's Pharmacy Compounding Advisory Committee session in 2027. But the committee is advisory only — even a favorable vote wouldn't itself make GHK-Cu legal to compound, and as of this writing nothing has changed its status. Anyone selling injectable GHK-Cu today is operating ahead of the rules, not inside them. The full regulatory map is in Are peptides legal? FDA rules explained.
Same molecule, different products
A copper-peptide serum from a licensed cosmetics brand and a "research use only" GHK-Cu vial are not the same product at different strengths — they're different legal categories entirely. The serum is a regulated cosmetic. The vial is an unapproved drug substance with no one accountable for what's inside. The name on the label doesn't transfer legitimacy between them.
Where Pallas stands
Pallas offers GHK-Cu in one form: as an ingredient in a prescription cream, the GHK-Cu peptide complex. It is compounded for each patient by a state-licensed pharmacy with tretinoin, caffeine, and niacinamide, and prescribed only when a US-licensed clinician decides it's appropriate. Compounded preparations are not FDA-approved.
Pallas does not offer GHK-Cu as an injection or in any oral form. We evaluate compounds one at a time and one route at a time, and the bar is the law: a lawful pathway, FDA-registered ingredient sourcing, a licensed pharmacy, and a licensed clinician making the prescribing decision. That is the same standard we apply to everything we offer.








